Feature|Videos|February 13, 2025 (Updated: March 4, 2025)
Lightship’s Approach to Accessible, Representative, and Impactful Clinical Trials
Author(s)Lightship
Sepehr Shojaei, VP of Design Solutions at Lightship, talks about how the company works with pharma and contract research organization (CRO) partners to support clinical trials that are patient-first and accessible.
Lightship prioritizes patient accessibility and centricity in clinical trials, ensuring a seamless and positive experience for every participant. Learn more about:
- Lightship's mission and core purpose as a company
- How Lightship’s mobile nursing teams and home visits enhance study participation and retention
- The role of mobile research units in the community and how they enhance participant education, accessibility, and convenience
Related Content
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
Protocol Design Doesn't Fail in the Protocol, It Fails in Transition to Trial
3
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
4
ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value
5